BRLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
BRLI' s Interest Coverage Range Over the Past 10 Years
Min: 0 Med: 0.00 Max: 0
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
|Joel Greenblatt 11,951 sh (New)|
Steven Cohen 46,800 sh (New)
Paul Tudor Jones 28,610 sh (+31.84%)
Mario Gabelli 59,000 sh (+1.72%)
|Chase Coleman 720,000 sh (unchged)|
John Hussman 59,000 sh (unchged)
|Chuck Royce 206,300 sh (-26.56%)|
|John Hussman 203,000 sh (+244.07%)|
Chuck Royce 289,100 sh (+40.14%)
Joel Greenblatt 13,925 sh (+16.52%)
Mario Gabelli 65,000 sh (+10.17%)
|Chase Coleman Sold Out|
Steven Cohen Sold Out
Paul Tudor Jones 21,100 sh (-26.25%)
|Jim Simons 57,804 sh (New)||John Hussman 203,000 sh (unchged)||Paul Tudor Jones Sold Out|
Joel Greenblatt Sold Out
Mario Gabelli 62,600 sh (-3.69%)
Chuck Royce 201,200 sh (-30.40%)
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
|Industry:||Medical Diagnostics & Research » Diagnostics & Research|
|Compare:||NAS:NEOG, SZSE:300439, NAS:KANG, SZSE:300482, LTS:0NBW, TSX:PTI » details|
|Traded in other countries:||BFR.Germany,|
Bio-Reference Laboratories Inc is a New Jersey corporation incorporated on December 24, 1981. It offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. It also offers laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The Company is engaged in esoteric testing, molecular diagnostics, anatomical pathology, genetics, womens health and correctional health care. The Company has a network of approximately 116 patient service centers located in the Northeast (in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in New Jersey, Maryland, Pennsylvania, Delaware and Connecticut. It offers laboratory services to physician offices in these areas with an infrastructure that includes a comprehensive logistical department, phlebotomy services and phlebotomy draw stations. The Company operates a clinical knowledge management service through its PSIMedica business unit. The system uses customer data from laboratory results, pharmaceutical data, claims data and other data sources provide administrative and clinical decision support systems that enable customers to provide quality and efficient healthcare to their populations. It also operates a web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. The Company competes with three types of providers in a highly fragmented and competitive industry: hospital laboratories, physician-office laboratories and other independent clinical laboratories. Its competitors in the New York metropolitan area are Quest Diagnostics (DGX) and Laboratory Corporation of America (LH). The Company is subject to federal and state laws and regulations regarding the protection of the environment, the health and safety of employees, and the handling, transportation and disposal of medical specimens, and infectious and hazardous wastes.
|Revenue (TTM) (Mil) $||882.5|
|EPS (TTM) $||1.83|
|Short Percentage of Float||15.74%|
|52-Week Range $||26.32 - 47.49|
|Shares Outstanding (Mil)||27.80|
|Small cap high short interest (Predictability = 5), Part 1 Oct 16 2014|
|Why I Like These Two Health Care Stocks Aug 29 2014|
|LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014|
|DaVita Seems to be a High-Growth Company Aug 20 2014|
|Small-Cap Consensus Picks By The Investing Gurus Jul 25 2014|
|4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of Apr 16 2014|
|Medical Diagnostic Labs Facing Medicare Headwinds Mar 25 2014|
|Historical Short Interest Of Stocks – New Feature Announcement Jan 17 2014|
|New Feature Announcement: Stocks With The Highest Short Interest Dec 12 2013|
|5 Ways to See Why Bio-Reference Labs Is a Solid Stock Mar 29 2013|